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Class III membrane proteins lack cleavable signal peptides but adopt an N-out, C-in topology with respect to their native membranes. We have 
analysed the fate of two eukaryotic class III plasma membrane proteins, human erythrocyte glycophorin C and influenza A virus M2 protein, in 
Escherzchza co/i. The N-terminal domains of both proteins were efficiently localised to the extracytoplasmic side of the bacterial cytoplasmic 
membrane. When /%actamase was fused to the C-terminus of glycophorm C it was localised to the cytoplasm. and protease treatment of 
spheroplasts caused a reduction in size of the fusion protein consistent with glycophorin C adopting its native topology m E. coli. 
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1. INTRODUCTION 
Simple membrane proteins fall into three topologi- 
tally distinct classes [l]. Class I membrane proteins pos- 
sess an N-terminal signal peptide which directs translo- 
cation of the polypeptide across the membrane until 
halted by a ‘stoptransfer’ sequence. The signal peptide 
is cleaved from the pre-protein producing a mature pro- 
tein with an N-out, C-in topology. Class II membrane 
proteins have an N-terminal uncleaved signal peptide 
which lodges in the membrane and translocates all 
downstream sequences, producing the N-in, C-out to- 
pology. Class III membrane proteins lack cleavable sig- 
nal peptides yet their N-termini are translocated across 
the membrane. Translocation is dependent upon a 
downstream ‘start-stop transfer’ sequence and results 
in an N-out, C-in topology. 
Gene fusion (topology) analysis has been used to 
demonstrate that representative class I and class II 
eukaryotic plasma membrane proteins expressed in 
Escherichia coli insert topologically correctly into the 
bacterial cytoplasmic membrane [2.3]. We have now 
analysed the fate in E. coli of two eukaryotic class III 
membrane proteins, human glycophorin C and the in- 
fluenza virus M2 protein. We show that the N-terminal 
domains of both are localised to the E. coli periplasm. 
Moreover, by fusing /3-lactamase towards the C-termi- 
nus of glycophorin C and determining the transmem- 
brane (TM) disposition of the fusion protein, we deduce 
that glycophorin C assembles topologically correctly 
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into the bacterial cytoplasmic membrane. Hence E. coli 
provides a suitable environment for the extracytoplas- 
mic localisation of the N-termini of these eukaryotic 
class III membrane proteins. 
2. MATERIALS AND METHODS 
2.1. Szrbcloning t/ze glycophorzn C coding regzon for bacterzul expres- 
szon and fuszon of p-lactamase to zts C-terminal domazn 
pYZ4 encodes a modified LacZ a-peptide with an NcoI site flanking 
its imtiation codon, under the control of the lac uv5 promoter [3]. 
Insertion of an intact codmg region between the NcoI site and another 
restriction site in the multiple cloning region ensures its direct expres- 
sion. Lmker taihng [4] was used to insert the first four codons of the 
glycophorin C gene, which include a unique SafI site, between the NcoI 
and Hind111 sites of pYZ4 using the ohgonucleotides dCAT- 
GTGGTCGACGTGATA and dAGCTTATCACGCGTCGACCA. 
A cDNA encoding glycophorm C lacking its three C-terminal codons 
was removed from BET1 [5] as a San-to-&z1 fragment and subcloned 
into pYZ4, thus creating pLHl1. The mature /I-lactamase coding 
region of pYZ5 [3] was fused m-frame to the C-terminally truncated 
gene by cutting pLH 11 with XbaI, end-filling (with dCTP and dTTP 
only), endtrimming and cutting with EcoRI and ligating to a PvuII- 
EcoRIp-lactamase fragment from pYZ5, making pLH12. A construct 
containing the entire coding region of glycophorin C (pEH5) was 
constructed by ligating a Sa&SmaI fragment from BET1 to pYZ4. 
All fusion junctions were verified by DNA sequencing using the Se- 
quenase II system (United States Biochemical Corp.) according to the 
manufacturer’s Instructions. 
2.2. Subcloning the injluen-u M2 coding region for bacterzal expression 
The polymerase chain reaction was used to amplify an M2 cDNA 
and simultaneously introduce a BspHI site spannmg its initiation 
codon using primers dAATCATGAGCCTTCTGACCGA and dTT- 
TACTCCAGCTCTATGCTGA. The amplified fragment was first 
cloned into an M13mp18 T-vector [6] then subcloned mto NcoI and 
EcoRI cut pEH1 (a derivative of pYZ4 that contains a phage T7 
promoter in addition to the lac uv5 promoter; E.S.H. and J.K.B-S., 
unpublished data) as an BspHIIEcoRI fragment, thus creating LHBl. 
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1.3. S~ntlwsrs ofthe rnernbrarte proteins in E cob and production artd 
proteuxe-treatmmt 0j”spherophsts 
Plasmids were transformed into E. coli stram 5K where the cloned 
gene products are synthesised constttuttvely. Cultures were grown to 
log phase at 37°C vvtth constant shaking. Cells were harvested by 
centrifugatton and the pellet resuspended in 1/80th ortgmal volume of 
25% (w/v) sucrose; 30 mM Tris-Cl. pH 8.0: I mM PMSF then made 
10 mM EDTA. 40 PM PMSF. Spheroplasts were produced by adding 
i/25th vol. lysozyme (10 mg/ml). Plasmid pLHB1 was also trans- 
formed into strain BL2l(DE3) which encodes T7 RNA polymerase 
under the control of the kac promoter [7]. Syntheses of M2 protein was 
induced by the addition of I mM IPTG to log phase cells. Cells were 
grown for a further hour and then pelleted by centrifugatton. Smce the 
outer membranes of BL’l(DE3) cells were resistant to permeabilisa- 
tion using EDTA and lysosyme. spheroplasts were produced using 
polymyxm B sulphate and lysosyme as described in [8]. 
Ahquots of spheroplasts were treated either with proteinase K (2.5 
mg/ml final concentratron) by mcubatmg at room temperature for 
5 min then stoppmg digestion with 5 mM PMSF. or with TPCK- 
treated trypsin (0.75 pg/ml) at 4°C for 60 mm. and digestton stopped 
by adding the inhibttors aprotinm (I TIU/ml) and PMSF (1 mM). 
Further ahquots were treated in an identical fashion except that the 
protease addrtion step was omitted. 
2 4. Protetn gels und Western hlottmg 
Samples were lysed by repeated cycles of freeze-thawing and then 
MgClz (10 mM) and DNase (IO @ml) were added. Samples were 
subjected to SDS-PAGE [9] and transferred to nitrocellulose. Primary 
antrbodies (diluted 1: 1 .OOO) were against /I-lactamase (Northumbrta 
Biologtcals Ltd.), a pepttde corresponding to the N-terminal I9 ammo 
acrds of glycophorm C (S. High, University of Manchester. and 
M Tanner, University of Bristol) or the N-terminus of fiu M2 protein 
[IO] An alkaline phosphatase-linked secondary anttbody (1: 1000 dilu- 
tion; Sigma Chemtcal Co.) was used Cross-reacting proteins were 
detected by Incubating the mtrocellulose m 100 mM NaCI. 5 mM 
MgC12, 100 mM Tris-Cl, pH 9.5, contammg mtroblue tetrazolium 
(0.033% (w/v)) and bromochloroindoyl phosphate. toluidme salt 
(0.017% (w/v)). The reactton was stopped by the additron of 20 mM 
EDTA. 
3. RESULTS AND DISCUSSION 
Glycophorin C is a 128 amino acid protein found in 
erythrocytes which adopts an N-out. C-in topology 
within the membrane with its N-terminal 58 amino 
acids being extracytoplasmic [5,1 I]. Cells of 5K( pEH5) 
synthesising glycophorin C were spheroplasted and in- 
cubated with proteinase K. SDS-PAGE and Western 
blotting using an antibody directed to the N-terminal 
19 amino acids of glycophorin C revealed that the N- 
terminus was localised to the periplasmic side of the E. 
coli cytoplasmic membrane (Fig. la). 
To verify the N-out, C-in topology of glycophorin C 
in E. co/i, B-lactamase was fused to the C-terminus of 
glycophorin C and spheroplasted cells of 5K(pLHl2) 
were treated as before. As expected, the N-terminal do- 
main of the glycophorin C portion was extracytoplas- 
mic (Fig. 1 a), and proteinase K treatment resulted in an 
apparent 7.5 kDa size reduction, as detected using 
p-lactamase antibody (Fig. 1 b). This is compatible with 
all but the predicted 7 kDa N-terminal domain of glyco- 
phorin C being protected from proteolysis. In a control 
reaction a cytoplasmic p-lactamase fusion protein. 
pYZ1 l/blaMll [3] remained proteinase K resistant in- 
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dicating that the cytoplasmic membrane had not been 
permeabilised (Fig. lc). 
When cells of 5K(pLHl2) were inoculated at high 
density onto L-agar plates containing increasing con- 
centrations of ampicillin, the minimum inhibitory con- 
centration of ampicillin was 150 pug/ml, a value that is 
within the range encountered for other /I-lactamase fu- 
sion proteins the detection of which requires Western 
blotting. However, when cells of 5K(pLH12) were inoc- 
ulated at low density, so that they were individualll 
exposed to the antibiotic, they failed to form colonies 
on agar containing 5 pug/ml ampicillin. The inability of 
the fusion protein to protect individual cells against 
ampicillin-induced lysis is an indicator of a cytoplasmic 
location for the p-lactamase moiety, and hence the C- 
terminal domain of glycophorin C (see [12,13] for re- 
views). 
The influenza A virus M2 protein is a 97 amino acid- 
long class III membrane protein, which assembles into 
the plasma membrane of infected cells with its N-termi- 
nal 20 (or so) residues forming the extracellular domain 
[14]. pLHB1 was transformed into 5K, but constitutive 
synthesis of the M2 protein from the luc uv5 promoter 
yielded no detectable cross-reacting product using the 
M2 antibody for the N-terminus (data not shown). 
Therefore pLHB1 was transformed into strain 
BL21 (DE3), and T7 promoter-mediated expression of 
the M2 gene was induced. When cells were converted to 
spheroplasts and trypsin treated this resulted in the loss 
of the N-terminal M2 epitope. indicating that this do- 
main achieves an extracytoplasmic location in E. coli 
(Fig. Id). 
The data presented here demonstrate that when 
glycophorin C or the M2 protein are synthesised in 
E. coli. their N-termini are on the periplasmic side of the 
cytoplasmic membrane. In the case of glycophorin C, 
further analysis demonstrates that it adopts its normal 
class III (N-out, C-in) topology in E. coli. 
Since protease treatment of spheroplasts removed all 
of the product that cross-reacted with the N-terminus 
specific antibodies (Fig. la and d) this suggests that few 
if any molecules of glycophorin C or the M? protein 
assemble into the E. coli cytoplasmic membrane with an 
inverted topology. The glycophorin C::,&lactamase fu- 
sion protein conferred no protection on cells against 
ampicillin-induced lysis, providing a further indication 
that glycophorin C assembles efficiently into the E. coli 
cytoplasmic membrane. The N-terminal domain of 
glycophorin C is normally extensively glycosylated. but 
since glycosylation does not occur in E. co/i we can 
conclude that such modification is not required for cor- 
rect assembly. 
The system described here allows the expression of 
eukaryotic class III TM proteins in E. coli while main- 
taining their correct topology relative to the cytoplas- 
mic membrane. The criteria that determine the translo- 
cation competence of N-terminal domains of class III 
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Fig. 1. TM orgamsation of glycophorin C and M2 protein in E. coli. Cells synthesismg glycophorin C, the glycophorm C::p-lactamase fusion protein, 
the M2 protein or the control pYZ1 l/blaM 11 were spheroplasted, protease treated, and subjected to SDS-PAGE and Western blotting as described 
in section 2. Proteins were run on 12.5% (w/v) polyacrylamide gel (a-c) or a 15% (w/v) polyacrylamtde gel (d) and detected using antibody to the 
N-terminus of glycophorm C (a), /I-lactamase (b and c). or the N-terminus of M2 protein (d). (a) Lanes 1 and 2. glycophorin C minus and plus 
proteinase K. Lanes 3 and 4: glycophorm C::B-lactamase minus and plus protemase K. (b) Lanes 1 and 2, glycophorm C::,&lactamase minus and 
plus proteinase K. (c) Lanes 1 and 2, control pYZ1 IlblaMl 1 mmus and plus proteinase K. (d) Lanes 1 and 2, M7 protein mmus and plus trypsin. 
The molecular wetghts (in kDa) of Rainbow marker protem standards (Amersham) are shown, 
proteins are relatively unexplored. The recent findings 
that two TM proteins (Unc-5 and Neu differentiation 
factor) with exceptionally large extracytoplasmic N-ter- 
minal domains probably lack cleavable signal peptides 
[15,16], and that the extracellular localisation of the 
relatively short N-terminal domain of the human /32- 
adrenergic receptor may be naturally inefficient [17], 
provide further impetus for examining these criteria. 
Such issues can be easily and quickly addressed using 
model class III membrane proteins in E. coli. It is 
known that the assembly of the M2 protein and glyco- 
phorin C into eukaryotic membranes is signal recogni- 
tion particle (SRP) dependent ([I81 and S. High, per- 
sonal communication). It will be interesting to deter- 
mine whether SRP of E. coli [19], or other bacterial 
chaperones, are required for the assembly of these pro- 
teins into the bacterial cytoplasmic membrane. 
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